Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis.

Neuroscience letters - 24 Aug 2022

Liu Chuanyong, Xu Xiaohong, Liu Xiaoyan, Zhang Teng, Li Yaoyao, Yan Pan

Abstract excerpt

The association between dopamine D3 receptor (DRD3) Ser9Gly polymorphism and treatment response to antipsychotic drugs (APDs) in schizophrenia (SCZ) has been widely reported with inconsistent results, thus we performed an updated meta-analysis to derive a more precise estimation of the relationship. PubMed, Cochrane Library, Medline, Embase, CNKI, Weipu and Wanfang databases were searched for eligible studies...

Topics

Antipsychotic Agents
Genetic Predisposition to Disease
Genotype
Humans
Male
Polymorphism, Genetic
Polymorphism, Single Nucleotide
Receptors, Dopamine D3
Schizophrenia

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35835396
DOI: 10.1016/j.neulet.2022.136788

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis.PMID 35835396Read ↗

Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia.Semantic proximity Read ↗

Association of 5-HTR2A T102C and A-1438G polymorphisms with clinical response to atypical antipsychotic treatment in schizophrenia: A meta-analysis.Semantic proximity Read ↗

The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis.Semantic proximity Read ↗

Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia.Semantic proximity Read ↗

Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.Semantic proximity Read ↗

No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studiesSemantic proximity Read ↗

The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis.Semantic proximity Read ↗

Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder.Semantic proximity Read ↗

Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.Semantic proximity Read ↗

Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.Semantic proximity Read ↗

Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis.Semantic proximity Read ↗

[Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.